Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution

Yearbook of Physical Anthropology

Volumn 44, Issue , 2001, Pages 54-69

  Varki, Ajit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Genomic mutation; Great apes; Human evolution; Sialic acids

Indexed keywords

CMPACETYLNEURAMINATE MONOOXYGENASE; MIXED FUNCTION OXIDASE; N ACETYLNEURAMINIC ACID; N-GLYCOLYLNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE;

ANIMAL; BRAIN; EVOLUTION; GENE EXPRESSION; GENETICS; GLYCOSYLATION; HOMINID; HUMAN; INFECTION; MAMMAL; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALS; BIOLOGICAL EVOLUTION; BRAIN; GENE EXPRESSION; GLYCOSYLATION; HOMINIDAE; HUMANS; INFECTION; MAMMALS; MIXED FUNCTION OXYGENASES; MUTATION; N-ACETYLNEURAMINIC ACID; NEURAMINIC ACIDS;

EID: 0001918159     PISSN: 0096848X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajpa.10018     Document Type: Article

References (154)

1. Ando N, Yamakawa T. 1982. On the minor gangliosides of erythrocyte membranes of Japanese cats. J Biochem (Tokyo) 91:873-881.
2. Andrews GA, Chavey PS, Smith JE, Rich L. 1992. N-glycolyl-neuraminic acid and N-acetylneuraminic acid define feline blood group A and B antigens. Blood 79:2485-2491.
3. Angata T, Varki A. 2001. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev (in press).
4. Angata T, Varki NM, Varki A. 2001. A second uniquely human mutation affecting sialic acid biology. J Biol Chem 276:40282-40287.
5. Bevilacqua MP, Nelson RM. 1993. Selectins. J Clin Invest 91: 379-387.
6. M3 ganglioside of the small intestine of inbred rats. J Biol Chem 264:16992-16999.
7. Bozue JA, Tullius MV, Wang J, Gibson BW, Munson RS Jr. 1999. Haemophilus ducreyi produces a novel sialyltransferase - identification of the sialyltransferase gene and construction of mutants deficient in the production of the sialic acid-containing glycoform of the lipooligosaccharide. J Biol Chem 274:4106-4114.
8. Brinkman-Van der Linden ECM, Sjoberg ER, Juneja LR, Crocker PR, Varki N, Varki A. 2000. Loss of N-glycolylneuraminic acid in human evolution - implications for sialic acid recognition by siglecs. J Biol Chem 275:8633-8640.
9. Caccone A, Powell JR. 1989. DNA divergences among hominids. Evolution 43:925-942.
10. Chatterji U, Sen AK, Schauer R, Chowdhury M. 2000. Paracrine effects of a uterine agglutinin are mediated via the sialic acids present in the rat uterine endometrium. Mol Cell Biochem 215:47-55.
11. Chen FC, Li WH. 2001. Genomic divergences between humans and other hominoids and the effective population size of the common ancestor of humans and chimpanzees. Am J Hum Genet 68:444-456.
12. Chou HH, Takematsu H, Diaz S, Iber J, Nickerson E, Wright KL, Muchmore EA, Nelson DL, Warren ST, Varki A. 1998. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 95:11751-11756.
13. Collins BE, Kiso M, Hasegawa A, Tropak MB, Roder JC, Crocker PR, Schnaar RL. 1997a. Binding specificities of the sialoadhesin family of I-type lectins - sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem 272:16889-16895.
14. Collins BE, Yang LJS, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A, Schnaar RL. 1997b. Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem 272:1248-1255.
15. Crocker PR, Feizi T. 1996. Carbohydrate recognition systems: Functional triads in cell-cell interactions. Curr Opin Struct Biol 6:679-691.
16. Crocker PR, Varki A. 2001a. Siglecs, sialic acids and innate immunity. Trends Immunol 22:337-342.
17. Crocker PR, Varki A. 2001b. Siglecs in the Immune system. Immunology 103:137-145.
18. Crocker PR, Mucklow S, Bouckson V, McWilliam A, Willis AC, Gordon S, Milon G, Kelm S, Bradfield P. 1994. Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO J 13:4490-4503.
19. Crocker PR, Clark EA, Filbin M, Gordon S, Jones Y, Kehrl JH, Kelm S, Le Douarin N, Powell L, Roder J, Schnaar RL, Sgroi DC, Stamenkovic K, Schauer R, Schachner M, Van den Berg TK, Van der Merwe PA, Watt SM, Varki A. 1998. Siglecs: a family of sialic-acid binding lectins [letter]. Glycobiology 8:v.
20. Delorme C, Brüssow H, Sidoti J, Roche N, Karlsson KA, Neeser JR, Teneberg S. 2001. Glycosphingolipid binding specificities of rotavirus: Identification of a sialic acid-binding epitope. J Virol 75:2276-2287.
21. DeLuca GM, Donnell ME, Carrigan DJ, Blackall DP. 1996. Plasmodium falciparum merozoite adhesion is mediated by sialic acid. Biochem Biophys Res Commun 225:726-732.
22. Deodhar SD. 1986. Review of xenografts in organ transplantation. Transplant Proc 18:83-87.
23. Devine PL, Clark BA, Birrell GW, Layton GT, Ward BG, Alewood PF, McKenzie IFC. 1991. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res 51:5826-5836.
24. Escalante AA, Ayala FJ. 1994. Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences. Proc Natl Acad Sci USA 91:11373-11377.
25. Escalante AA, Barrio E, Ayala FJ. 1995. Evolutionary origin of human and primate malarias: evidence from the circumsporozoite protein gene. Mol Biol Evol 12:616-626.
26. Freeze HH. 1999. Human glycosylation disorders and sugar supplement therapy. Biochem Biophys Res Commun 255:189-193.
27. Fujii Y, Higashi H, Ikuta K, Kato S, Naiki M. 1982. Specificities of human heterophilic Hanganutziu and Deicher (H-D) antibodies and avian antisera against H-D antigen-active glycosphingolipids. Mol Immunol 19:87-94.
28. 252Cf fission fragment ionization mass spectrometry in the analysis of glycosphingolipids. J Biol Chem 263:14939-14947.
29. Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO. 1988b. Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies. J Biol Chem 263:18507-18512.
30. Gagneux P, Varki A. 1999. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9:747-755.
31. Gagneux P, Varki A. 2001. Genetic differences between humans and great apes. Mol Phylogenet Evol 18:2-13.
32. Gagneux P, Wills C, Gerloff U, Tautz D, Morin PA, Boesch C, Fruth B, Hohmann G, Ryder OA, Woodruff DS. 1999. Mitochondrial sequences show diverse evolutionary histories of African hominoids. Proc Natl Acad Sci USA 96:5077-5082.
33. Goodman M, Bailey WJ, Hayasaka K, Stanhope MJ, Slightom J, Czelusniak J. 1994. Molecular evidence on primate phylogeny from DNA sequences. Am J Phys Anthropol 94:3-24.
34. Gottschalk A. 1960. The chemistry and biology of sialic acids and related substances. Cambridge: Cambridge University Press.
35. Greenwood AD, Capelli C, Possnert G, Paabo S. 1999. Nuclear DNA sequences from late Pleistocene megafauna. Mol Biol Evol 16:1466-1473.
36. Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. 2001. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97:288-296.
37. Hashimoto Y, Yamakawa T, Tanabe Y. 1984. Further studies on the red cell glycolipids of various breeds of dogs. A possible assumption about the origin of Japanese dogs. J Biochem (Tokyo) 96:1777-1782.
38. Hayakawa T, Satta Y, Gagneux P, Varki A, Takahata N. 2001. Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid hydroxylase gene. Proc Natl Acad Sci USA 98:11399-11404.
39. Hennet T, Chui D, Paulson JC, Marth JD. 1998. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA 95:4504-4509.
40. Higa HH, Paulson JC. 1985. Sialylation of glycoprotein oligosaccharides with N-acetyl-, N-glycolyl-, and N-O-diacetylneuraminic acids. J Biol Chem 260:8838-8849.
41. Higa HH, Rogers GN, Paulson JC. 1985. Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-, N-glycolyl-, and N,O-diacetylneuraminic acids. Virology 144:279-282.
42. Higashi H, Naiki M, Matuo S, Okouchi K. 1977. Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid. Biochem Biophys Res Commun 79:388-395.
43. Higashi H, Nishi Y, Fukui Y, Ikuta K, Ueda S, Kato S, Fujita M, Nakano Y, Taguchi T, Sakai S. 1984. Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers. Gann 75:1025-1029.
44. Higashi H, Sasabe T, Fukui Y, Maru M, Kato S. 1988. Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells. Jpn J Cancer Res 79:952-956.
45. Hirabayashi Y, Higashi H, Kato S, Taniguchi M, Matsumoto M. 1987a. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas. Jpn J Cancer Res 78:614-620.
46. Hirabayashi Y, Kasakura H, Matsumoto M, Higashi H, Kato S, Kasai N, Naiki M. 1987b. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers. Jpn J Cancer Res 78:251-260.
47. Hofreiter M, Serre D, Poinar HN, Kuch M, Paabo S. 2001. Ancient DNA. Nat Rev Genet 2:353-359.
48. Hokke CH, Bergwerff AA, Van Dedem GWK, Kamerling JP, Vliegenthart JFG. 1995. Structural analysis of the sialylated N-and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells - sialylation patterns and branch location of dimeric N-acetyllactosamine units. Eur J Biochem 228:981-1008.
49. Ikuta K, Nishi Y, Shimizu Y, Higashi H, Kitamoto N, Kato S, Fujita M, Nakano Y, Taguchi T, Naiki M. 1982. Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence. Biken J 25:47-50.
50. Inoue S, Kitajima K, Inoue Y. 1996. Identification of 2-keto-3-deoxy-D-glycero-D-galactonononic acid (KDN, deaminoneuraminic acid) residues in mammalian tissues and human lung carcinoma cells. J Biol Chem 271:24341-24344.
51. Irie A, Koyama S, Kozutsumi Y, Kawasaki T, Suzuki A. 1998. The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem 273:15866-15871.
52. Ito T, Kawaoka Y. 2000. Host-range barrier of influenza A viruses. Vet Microbiol 74:71-75.
53. Ito T, Suzuki Y, Mitnaul L, Vines A, Kida H, Kawaoka Y. 1997. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 227:493-499.
54. Ito T, Suzuki Y, Suzuki T, Takda A, Horimoto T, Wells K, Kida H, Otsuki K, Kiso M, Ishida H, Kawaoka Y. 2000. Recognition of N-glycolylneuraminic acid linked to galactose by the α2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 74:9300-9305.
55. Kaessmann H, Wiebe V, Weiss G, Paabo S. 2001. Great ape DNA sequences reveal a reduced diversity and an expansion in humans. Nat Genet 27:155-156.
56. Kansas GS. 1996. Selectins and their ligands: current concepts and controversies. Blood 88:3259-3287.
57. Karlsson KA. 1998. Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Mol Microbiol 29:1-11.
58. Karlsson KA. 2000. The human gastric colonizer Helicobacter pylori: a challenge for host-parasite glycobiology. Glycobiology 10:761-771.
59. Kasukawa R, Kano K, Bloom ML, Milgrom F. 1976. Heterophile antibodies in pathologic human sera resembling antibodies stimulated by foreign species sera. Clin Exp Immunol 25:122-132.
60. Kawachi S, Saida T. 1992. Analysis of the expression of Hanganutziu-Deicher (HD) antigen in human malignant melanoma. J Dermatol 19:827-830.
61. Kawai T, Kato A, Higashi H, Kato S, Naiki M. 1991. Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. Cancer Res 51:1242-1246.
62. Kawano T, Koyama S, Takematsu H, Kozutsumi Y, Kawasaki H, Kawashima S, Kawasaki T, Suzuki A. 1995. Molecular cloning of cytidine monophospho-N-acetylneuraminic acid hydroxylase. Regulation of species-and tissue-specific expression of N-glycolylneuraminic acid. J Biol Chem 270:16458-16463.
63. Kelm S, Schauer R. 1997. Sialic acids in molecular and cellular interactions. Int Rev Cytol 175:137-240.
64. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, De Bellard M-E, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, Crocker PR. 1994a. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol 4:965-972.
65. Kelm S, Schauer R, Manuguerra J-C, Gross H-J, Crocker PR. 1994b. Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconjugate J 11:576-585.
66. Kelm S, Brossmer R, Isecke R, Gross HJ, Strenge K, Schauer R. 1998. Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur J Biochem 255:663-672.
67. King MC, Wilson AC. 1975. Evolution at two levels in humans and chimpanzees. Science 188:107-116.
68. Klotz FW, Orlandi PA, Reuter G, Cohen SJ, Haynes JD, Schauer R, Howard RJ, Palese P, Miller LH. 1992. Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol 51:49-54.
69. 5 in CMP-N-acetylneuraminic acid hydroxylation in mouse liver cytosol. J Biochem (Tokyo) 108:704-706.
70. Krings M, Stone A, Schmitz RW, Krainitzki H, Stoneking M, Paabo S. 1997. Neandertal DNA sequences and the origin of modern humans. Cell 90:19-30.
71. Kyogashima M, Ginsburg V, Krivan HC. 1989. Escherichia coli K99 binds to N-glycolylsialoparagloboside and N-glycolyl-GM3 found in piglet small intestine. Arch Biochem Biophys 270:391-397.
72. Lander ES, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
73. Lanne B, Uggla L, Stenhagen G, Karlsson K-A. 1995. Enhanced binding of enterotoxigenic Escherichia coli K99 to amide derivatives of the receptor ganglioside NeuGc-GM3. Biochemistry 34:1845-1850.
74. Lepers A, Shaw L, Cacan R, Schauer R, Montreuil J, Verbert A. 1989. Transport of CMP-N-glycoloylneuraminic acid into mouse liver Golgi vesicles. FEBS Lett 250:245-250.
75. Malykh YN, Schauer R. 2001. N-glycolylneuraminic acid in tumors. Biochimie 83:623-634.
76. Marquina G, Waki H, Fernandez LE, Kon K, Carr A, Valiente O, Perez R, Ando S. 1996. Gangliosides expressed in human breast cancer. Cancer Res 56:5165-5171.
77. McConkey EH, Goodman M. 1997. A Human Genome Evolution Project is needed [letter]. Trends Genet 13:350-351.
78. McConkey EH, Varki A. 2000. A primate Genome Project deserves high priority. Science 289:1295-1296.
79. McConkey EH, Fouts R, Goodman M, Nelson D, Penny D, Ruvolo M, Sikela J, Stewart CB, Varki A, Wise S. 2000. Proposal for a Human Genome Evolution Project. Mol Phylogenet Evol 15: 1-4.
80. Merrick JM, Zadarlik K, Milgrom F. 1978. Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing N-glycolylneuraminic acid. Int Arch Allergy Appl Immunol 57:477-480.
81. Mikami T, Kashiwagi M, Tsuchihashi K, Daino T, Akino T, Gasa S. 1998. Further characterization of equine brain gangliosides: the presence of GM3 having N-glycolyl neuraminic acid in the central nervous system. J Biochem (Tokyo) 123:487-491.
82. Mitsuoka C, Ohmori K, Kimura N, Kanamori A, Komba S, Ishida H, Kiso M, Kannagi R. 1999. Regulation of selectin binding activity by cyclization of sialic acid moiety of carbohydrate ligands on human leukocytes. Proc Natl Acad Sci USA 96: 1597-1602.
83. Morito T, Kano K, Milgrom F. 1982. Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases. J Immunol 129:2524-2528.
84. Morito T, Nishimaki T, Masaki M, Yoshida H, Kasukawa R, Nakarai H, Kano K. 1986. Studies on Hanganutziu-Deicher antigens-antibodies. I. Hanganutziu-Deicher antibodies of IgG class in liver diseases. Int Arch Allergy Appl Immunol 81:204-208.
85. Muchmore EA, Milewski M, Varki A, Diaz S. 1989. Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool. J Biol Chem 264:20216-20223.
86. Muchmore EA, Diaz S, Varki A. 1998. A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol 107:187-198.
87. Nakao T, Kon K, Ando S, Hirabayashi Y. 1991. A NeuGc-containing trisialoganglioside of bovine brain. Biochim Biophys Acta Lipids Lipid Metab 1086:305-309.
88. Nakarai H, Saida T, Shibata Y, Irie RF, Kano K. 1987. Expression of heterophile, Paul-Bunnell and Hanganutziu-Deicher antigens on human melanoma cell lines. Int Arch Allergy Appl Immunol 83:160-166.
89. Nath D, Hartnell A, Happerfield L, Miles DW, Burchell J, Taylor-Papadimitriou J, Crocker PR. 1999. Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin. Immunology 98:213-219.
90. Nishimaki T, Kano K, Milgrom F. 1979. Hanganutziu-Deicher antigen and antibody in pathologic sera and tissues. J Immunol 122:2314-2318.
91. Noguchi A, Mukuria CJ, Suzuki E, Naiki M. 1996. Failure of human immunoresponse to N-glycolylneuraminic acid epitope contained in recombinant human erythropoietin. Nephron 72: 599-603.
92. Nohle U, Schauer R. 1981. Uptake, metabolism and excretion of orally and intravenously administered, 14C-and 3H-labeled N-acetylneuraminic acid mixture in the mouse and rat. Hoppe Seylers Z Physiol Chem 362:1495-1506.
93. Nohle U, Schauer R. 1984. Metabolism of sialic acids from exogenously administered sialyllactose and mucin in mouse and rat. Hoppe Seylers Z Physiol Chem 365:1457-1467.
94. Nohle U, Beau JM, Schauer R. 1982. Uptake, metabolism and excretion of orally and intravenously administered, double-labeled N-glycoloylneuraminic acid and single-labeled 2-deoxy-2,3-dehydro-N-acetylneuraminic acid in mouse and rat. Eur J Biochem 126:543-548.
95. Ohashi Y, Sasabe T, Nishida T, Nishi Y, Higashi H. 1983. Hanganutziu-Deicher heterophile antigen in human retinoblastoma cells. Am J Ophthalmol 96:321-325.
96. Ollomo B, Karch S, Bureau P, Elissa N, Georges AJ, Millet P. 1997. Lack of malaria parasite transmission between apes and humans in Gabon. Am J Trop Med Hyg 56:440-445.
97. Ouadia A, Karamanos Y, Julien R. 1992. Detection of the ganglioside N-glycolyl-neuraminyl-lactosyl-ceramide by biotinylated Escherichia coli K99 lectin. Glycoconjugate J 9:21-26.
98. Powell LD, Varki A. 1995. I-type lectins. J Biol Chem 270:14243-14246.
99. + T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 12: 273-283.
100. Qari SH, Shi YP, Pieniazek NJ, Collins WE, Lal AA. 1996. Phylogenetic relationship among the malaria parasites based on small subunit rRNA gene sequences: monophyletic nature of the human malaria parasite, Plasmodium falciparum. Mol Phylogenet Evol 6:157-165.
101. Rademacher TW, Parekh RB, Dwek RA. 1988. Glycobiology. Annu Rev Biochem 57:785-838.
102. Raju TS, Briggs JB, Borge SM, Jones AJS. 2000. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10:477-486.
103. Reed MB, Caruana SR, Batchelor AH, Thompson JK, Crabb BS, Cowman AF. 2000. Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion. Proc Natl Acad Sci USA 97:7509-7514.
104. Reemtsma K. 1989. Xenografts. Transplant Proc 21:517-518.
105. Rosenberg A, Schengrund C. 1976. Biological roles of sialic acids. New York and London: Plenum Press. p 295-359.
106. Rutishauser U, Landmesser L. 1996. Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions. Trends Neurosci 19:422-427.
107. Ruvolo M. 1997. Molecular phylogeny of the hominoids: inferences from multiple independent DNA sequence data sets. Mol Biol Evol 14:248-265.
108. Saida T, Ikegawa S, Takizawa Y, Kawachi S. 1990. Immunohistochemical detection of heterophile Hanganutziu-Deicher antigen in human malignant melanoma. Arch Dermatol Res 282: 179-182.
109. Sandvig K, Prydz K, Ryd M, van Deurs B. 1991. Endocytosis and intracellular transport of the glycolipid-binding ligand shiga toxin in polarized MDCK cells. J Cell Biol 113:553-562.
110. Schauer R. 1982. Sialic acids: chemistry, metabolism and function, cell biology monographs, volume 10. New York: Springer-Verlag.
111. Schlenzka W, Shaw L, Keim S, Schmidt CL, Bill E, Trautwein AX, Lottspeich F, Schauer R. 1996. CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya. FEBS Lett 385:197-200.
112. Schwegmann C, Zimmer G, Yoshino T, Enss ML, Herrler G. 2001. Comparison of the sialic acid binding activity of transmissible gastroenteritis coronavirus and E-coli K99. Virus Res 75:69-73.
113. Sgroi D, Varki A, Braesch-Andersen S, Stamenkovic I. 1993. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem 268:7011-7018.
114. Sharon N. 1996. Carbohydrate-lectin interactions in infectious disease. Adv Exp Med Biol 408:1-8.
115. Shaw L, Schauer R. 1988. The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid. Biol Chem Hoppe Seyler 369:477-486.
116. Shaw L, Schneckenburger P, Carlsen J, Christiansen K, Schauer R. 1992. Mouse liver cytidine-5′-monophosphate-TV-acetylneuraminic acid hydroxylase - catalytic function and regulation. Eur J Biochem 206:269-277.
117. 5-dependent electron transport chains. Eur J Biochem 219:1001-1011.
118. Sibley CG, Ahlquist JE. 1987. DNA hybridization evidence of hominoid phylogeny: results from an expanded data set. J Mol Evol 26:99-121.
119. Sjoberg ER, Chammas R, Ozawa H, Kawashima I, Khoo K-H, Morris HR, Dell A, Tai T, Varki A. 1995. Expression of de-N-acetyl-gangliosides in human melanoma cells is induced by genistein or nocodazole. J Biol Chem 270:2921-2930.
120. Smith CI, Chamberlain AT, Riley MS, Cooper A, Stringer CB, Collins MJ. 2001. Neanderthal DNA. Not just old but old and cold? Nature 410:771-772.
121. Stacker SA, Thompson C, Riglar C, McKenzie IF. 1985. A new breast carcinoma antigen defined by a monoclonal antibody. J Natl Cancer Inst 75:801-811.
122. Suzuki T, Horiike G, Yamazaki Y, Kawabe K, Masuda H, Miyamoto D, Matsuda M, Nishimura SI, Yamagata T, Ito T, Kida H, Kawaoka Y, Suzuki Y. 1997. Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium. FEBS Lett 404:192-196.
123. Suzuki Y, Nagao Y, Kato H, Matsumoto M, Nerome K, Nakajima K, Nobusawa E. 1986. Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached. J Biol Chem 261:17057-17061.
124. Takahata N, Satta Y. 1997. Evolution of the primate lineage leading to modern humans: phylogenetic and demographic inferences from DNA sequences. Proc Natl Acad Sci USA 94: 4811-4815.
125. 5, CMP-N-acetylneuraminic acid, and a hydroxylation enzyme. J Biochem (Tokyo) 115:381-386.
126. Takiguchi M, Tamura T, Goto M, Kusakawa S, Milgrom F, Kano K. 1984. Immunological studies on Kawasaki disease. I. Appearance of Hanganutziu-Deicher antibodies. Clin Exp Immunol 56:345-352.
127. Taubenberger JK, Reid AH, Fanning TG. 2000. The 1918 influenza virus: a killer comes into view. Virology 274:241-245.
128. Tettamanti G, Bertona L, Berra B, Zambotti V. 1965. Glycolylneuraminic acid in ox brain gangliosides. Nature 206:192.
129. Traving C, Schauer R. 1998. Structure, function and metabolism of sialic acids. Cell Mol Life Sci 54:1330-1349.
130. Troy FA II. 1992. Polysialylation: from bacteria to brains. Glycobiology 2:5-23.
131. Tsuji S, Datta AK, Paulson JC. 1996. Systematic nomenclature for sialyltransferases. Glycobiology 6:V-VII.
132. Vamecq J, Poupaert JH. 1990. Studies on the metabolism of glycolyl-CoA. Biochem Cell Biol 68:846-851.
133. Vamecq J, Mestdagh N, Henichart J-P, Poupaert J. 1992. Subcellular distribution of glycolyltransferases in rodent liver and their significance in special reference to the synthesis of N-glycolylneuraminic acid. J Biochem (Tokyo) 111:579-583.
134. Varki A. 1992. Diversity in the sialic acids. Glycobiology 2:25-40.
135. Varki A. 1994. Selectin ligands. Proc Natl Acad Sci USA 91:7390-7397.
136. Varki A. 1997. Sialic acids as ligands in recognition phenomena. FASEB J 11:248-255.
137. Varki A. 1998. Factors controlling the glycosylation potential of the Golgi apparatus. Trends Cell Biol 8:34-40.
138. Varki A. 1999a. Historical background and overview. In: Varki A, Esko JD, Cummings R, Freeze HH, Hart GW, Marth J, editors. Essentials of glycobiology. Plainview, NY: Cold Spring Harbor Laboratory Press. p 1-16.
139. Varki A. 1999b. Sialic acids. In: Varki A, Esko JD, Cummings R, Freeze HH, Hart GW, Marth J, editors. Essentials of glycobiology. Plainview, NY: Cold Spring Harbor Laboratory Press. p 195-210.
140. Varki A. 2000. A chimpanzee genome project is a biomedical imperative. Genome Res 10:1065-1070.
141. Varki A, Marth J. 1995. Oligosaccharides in vertebrate development. Semin Dev Biol 6:127-138.
142. Venter JC, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
143. Verheijen FW, Verbeek E, Aula N, Beerens CEMT, Havelaar AC, Joosse M, Peltonen L, Aula P, Galjaard H, Van der Spek PJ, Mancini GMS. 1999. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet 23:462-465.
144. Wang DQ, Fukui Y, Ito T, Nakajima K, Kato S, Naiki M, Kurimura T, Wakamiya N. 1990. Heterogeneity of Hanganutziu-Deicher antigen glycoproteins in different species animal sera. Nippon Juigaku Zasshi 52:567-572.
145. Warren L. 1963. The distribution of sialic acids in nature. Comp Biochem Physiol 10:153-171.
146. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC. 1988. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333:426-431.
147. Wessels MR, Rubens CE, Benedi V-J, Kasper DL. 1989. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci USA 86:8983-8987.
148. Willemsen PTJ, de Graaf FK. 1993. Multivalent binding of K99 fimbriae to the N-glycolyl-GM3 ganglioside receptor. Infect Immun 61:4518-4522.
149. Wilson IA, Skehel JJ, Wiley DC. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289:366-373.
150. Wood B, Collard M. 1999. Anthropology - the human genus. Science 284:65-66.
151. Yasue S, Handa S, Miyagawa S, Inoue J, Hasegawa A, Yamakawa T. 1978. Difference in form of sialic acid in red blood cell glycolipids of different breeds of dogs. J Biochem (Tokyo) 83:1101-1107.
152. Ye J, Kitajima K, Inoue Y, Inoue S, Troy FA II. 1994. Identification of polysialic acids in glycoconjugates. Methods Enzymol 230:460-484.
153. Yunis JJ, Prakash O. 1982. The origin of man: a chromosomal pictorial legacy. Science 215:1525-1530.
154. M3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J Biol Chem 269:1959-1965.